B

    BRC Group Holdings, Inc. (RILYL)

    Official site

    FINANCIAL SERVICES • FINANCIAL CONGLOMERATES • NASDAQ

    $13.47
    -0.06 (-0.41%)

    Market Cap: $536.57M

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    		$2.23$0.00N/ABeat-13.6%
    Jun 25
    		$-8.22$0.00N/AMiss-193.3%
    Dec 24
    		$-4.84$0.00N/AMiss-173.9%
    Jun 21
    		$1.69$0.00N/ABeat-3.4%
    Mar 21
    		$2.58$0.00N/ABeat-16.0%
    Dec 20
    		$8.81$0.00N/ABeat+330.0%
    Sep 20
    		$6.55$0.00N/ABeat+1018.8%
    Jun 20
    		$1.75$0.00N/ABeat+44.6%
    Mar 20
    		$3.07$0.00N/ABeat+274.4%
    Dec 19
    		$-3.83$0.00N/AMiss-1377.1%
    Sep 19
    		$0.59$0.00N/ABeat+273.2%
    Jun 19
    		$1.21$0.00N/ABeat+1110.0%
    Mar 19
    		$0.82$0.00N/ABeat+28.1%
    Dec 18
    		$0.30$0.00N/ABeat+76.5%
    Sep 18
    		$-0.34$0.00N/AMiss-44.5%
    Jun 18
    		$0.10$0.00N/ABeat+900.0%
    Mar 18
    		$0.64$0.00N/ABeat+326.7%
    Dec 17
    		$0.17$0.00N/ABeat-76.1%
    Sep 17
    		$-0.23$0.00N/AMiss-136.5%
    Jun 17
    		$0.01$0.00N/ABeat-
    Mar 17
    		$0.15$0.00N/ABeat-
    Dec 16
    		$0.71$0.00N/ABeat-
    Sep 16
    		$0.64$0.00N/ABeat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    Frequency4
    View RILYL's full dividend history

    Key Metrics

    Valuation
    P/E Ratio-1.47EV/EBITDAN/A
    Price/FCF1.40xFCF Yield71.34%
    Profitability
    Profit Margin38.60%Operating Margin11.80%
    ROE-3385.00%ROIC34.14%
    Financial Health
    Debt/Equity8.99xInterest Coverage6.14x
    Current Ratio2.61xQuick Ratio1.89x
    Trading Statistics
    Beta1.22Avg Volume6.20K
    52-Week High$18.0852-Week Low$3.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$13.34
    SMA 20$13.54
    SMA 50$13.95
    SMA 200$11.58
    EMA 10$13.44
    EMA 20$13.52
    EMA 50$13.89
    EMA 200$12.01

    MACD

    Line: -0.16Signal: -0.21Hist: 0.05

    ADX

    ADX: 26.2+DI: 16.8-DI: 31.0

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down12.0
    PSAR$13.97

    Bollinger Bands

    Upper Band$14.04
    Lower Band$13.05
    %B Position731%(Upper)
    Band Width0.43

    RSI (14-Day)

    Neutral
    46.6

    Momentum Oscillators

    Stoch %K48.1
    Stoch %D42.5
    Williams %R-50.0
    ROC (10d)-1.0%
    Momentum-0.13
    CCI (20d)-63.9
    MFI (14d)28.0

    Volatility Measures

    ATR (14d)$0.37(2.7%)
    StdDev (20d)0.25
    Hist Vol21.3%(Moderate)

    Volume Flow

    VWAP$13.32
    OBV1.5M
    AD Line582.4K
    CMF (20d)0.233

    Volume Metrics

    Avg Vol (20d)5.9K
    Vol Ratio2.2x(High)
    VWMA (20d)$13.57

    Pivot Points

    R3$13.53
    R2$13.53
    R1$13.53
    Pivot Point$13.53
    S1$13.53
    S2$13.53
    S3$13.53

    Advanced Oscillators

    TSI-11.67
    Ultimate Osc61.1
    KST-28.05

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$246.96M$450.62M$307.06M$234.72M$267.61M$194.16M$246.84M$246.84M$270.47M$309.79M$305.09M$364.13M
    Cost of Revenue$76.73M$79.96M$87.62M$87.71M$95.70M$80.15M$96.33M$96.33M$121.75M$133.88M$144.58M$133.20M
    Gross Profit$170.24M$370.65M$219.44M$147.00M$171.91M$114.01M$150.51M$150.51M$148.72M$175.91M$160.51M$230.93M
    Operating Expenses$112.49M$117.05M$118.78M$112.21M$326.93M$255.64M$232.67M$328.88M$475.35M$191.93M$205.85M$238.91M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$133.38M$134.35M$146.10M$143.89M$26.56M$167.39M$182.40M$161.07M$178.01M$11.60M$205.70M$215.64M
    Operating Income$57.75M$253.60M$100.66M$34.80M$-155,017,000$-61,477,000$-82,157,000$-82,041,000$-204,879,000$-16,019,000$-45,331,000$-7,982,000
    Interest Income$339,000$358,000$241,000$1.49M$492,000$1.49M$712,000$1.43M$797,000$669,000$420,000$180,000
    Interest Expense$18.02M$19.79M$20.05M$23.95M$31.11M$29.96M$33.00M$33.00M$33.53M$35.66M$46.89M$37.49M
    Income Before Tax$27.55M$239.05M$79.22M$74.74M$-251,138,000$-23,004,000$-140,661,000$-140,661,000$-419,968,000$-82,631,000$-110,647,000$-123,687,000
    Income Tax Expense$5.95M$16.89M$-11,079,000$3.05M$4.21M$0$9.95M$0$0$-21,330,000$-42,853,000$-23,638,000
    Net Income$20.55M$213.27M$86.84M$72.68M$2.89M$-9,975,000$-284,397,000$-284,397,000$-433,604,000$-49,165,000$-68,027,000$-73,823,000
    EBITDA$53.11M$266.43M$107.21M$107.40M$-208,747,000N/A$-96,474,000N/AN/A$-35,829,000$-33,829,000$-73,703,000
    EBIT$45.56M$258.84M$99.27M$98.69M$-220,025,000N/A$-107,665,000N/AN/A$-46,966,000$-45,331,000$-86,194,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RILYL

    News

    B Riley Financial Inc (RILY) Cash Flow

    This article provides a detailed cash flow statement for B Riley Financial Inc (RILY), including quarterly and annual data for operating, investing, and financing activities. It presents financial figures such as net income, capital expenditures, and free cash flow over several years. The content also addresses frequently asked questions about different types of cash flow and their significance for RILY.

    TradingKey•7/27/26•
    Neutral

    B.Riley reiterates Compass Pathways stock rating citing launch setup By Investing.com

    B.Riley has reiterated a Buy rating and a $17.00 price target for Compass Pathways (CMPS) following the firm's Mind, Muscle and Vision Summit. The stock currently trades at $12.35, suggesting a potential upside of 37%. Insights suggest a first-half 2027 approval and launch window for COMP360 in treatment-resistant depression, with multiple lines of evidence pointing to an expanded patient pool.

    Investing.com Canada•7/20/26•
    Neutral

    Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit

    Vanda Pharmaceuticals (Nasdaq: VNDA) announced its participation in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts, scheduled for July 16, 2026. This appearance provides another investor touchpoint, though analysts note it offers no new fundamental insights, contrasting with past price-moving regulatory and product milestones. The company's active S-3 shelf registration and moderate short interest are highlighted as factors investors may monitor for future capital-raising or pipeline updates.

    Stock Titan•7/10/26•
    Neutral

    Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit

    Vanda Pharmaceuticals Inc. announced its participation in the B. Riley Securities Mind, Muscle & Vision Summit, where it will hold a fireside chat on Thursday, July 16, 2026, in Boston, Massachusetts. Vanda Pharmaceuticals is a global biopharmaceutical company focused on developing and commercializing innovative therapies for unmet medical needs.

    PR Newswire•7/10/26•
    Neutral

    B.Riley raises Angel Studios stock price target to $8 on guild growth

    B.Riley increased its price target for Angel Studios Inc. (NYSE:ANGX) to $8.00 from $7.00, maintaining a Buy rating, due to anticipated healthy Angel Guild revenue growth and higher second-quarter paying Guild members. The firm expects 44% revenue growth for fiscal 2026, citing strong Q1 2026 performance with 238% revenue growth and positive Adjusted EBITDA. The increase reflects confidence in the company's improved film slate and a pure-play business model, with the new target suggesting a 125% return potential.

    Investing.com•6/30/26•
    Neutral

    Frequently Asked Questions About RILYL

    Does RILYL pay dividends?
    BRC Group Holdings, Inc. (RILYL) has a dividend payment track record. See the RILYL dividend history page for its current payment status, yield, and streaks.
    What is RILYL's market cap?
    BRC Group Holdings, Inc. (RILYL) has a market capitalization of $536.57M with a current stock price of $13.47.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In